scholarly journals Circulating Tumor Cells in Soft Tissue Sarcomas Patients

2012 ◽  
Vol 23 ◽  
pp. ix489 ◽  
Author(s):  
B. Vincenzi ◽  
E. Rossi ◽  
A. Zoccoli ◽  
M. Iuliani ◽  
F. Pantano ◽  
...  
2018 ◽  
Vol 19 (6) ◽  
pp. 454-460 ◽  
Author(s):  
Alexcia Camila Braun ◽  
Celso Abdon Lopes de Mello ◽  
Marcelo Corassa ◽  
Emne Ali Abdallah ◽  
Ana Cláudia Urvanegia ◽  
...  

2021 ◽  
Vol 20 (5) ◽  
pp. 58-74
Author(s):  
A. B. Danilova ◽  
T. L. Nekhaeva ◽  
N. A. Efremova ◽  
M. A. Maydin ◽  
E. I. Fedoros ◽  
...  

Background. To solve the problems of personalized medicine in oncology, preclinical studies based on the use of three-dimensional cellular models of tumors in vitro, including spheroids / tumoroids, are of great importance. They are an interesting tool for genetic, epigenetic, biomedical and pharmacological studies aiming to determine the most effective individual therapeutic approaches, since they allow modeling the dynamic evolution of a tumor disease from early stages to metastatic spread through interaction with the microenvironment.The purpose of the study was to compare characteristic features of formation and spatial organization of spheroids, obtained from solid malignant tumors cells with various histogenesis: melanomas, soft tissue sarcomas and osteosarcomas, epithelial tumors.Material and Methods. Solid tumor cell lines of patients who were treated from 2015 to 2021 were the basis for the creation of 3D-cell models. Fragments of tumor tissue were obtained intraoperatively: 15 samples of melanoma, 20 samples of soft tissue sarcomas and osteosarcomas, and 9 samples of epithelial tumors. All tumor cells were cultured for at least 10 passages. Methods of phase contrast, confocal microscopy, and histological techniques were used to study spheroids. Using ELISA methods and multiplex analysis, the supernatants of monolayer cell cultures and spheroids were studied for the presence of a wide range of biologically active substances that provide the processes of immunosuppression, invasion and metastasis.Results. The use of low adhesion surfaces was proven to be preferable to obtain spheroids of a given seed concentration and size of interest. The average cultivation time of spheroids was 4.7 days, and the optimal seeding concentration was 10,000 cells per well, while the spheroid diameter varied from 300 to 1000 μm depending on the type of malignant cells: the largest spheroids formed melanoma cultures. In general, the efficiency of spheroid formation was 88.6 % (39 out of 44). The introduction of fibroblasts into the 3D construct led to increasing in the invasive potential of tumor cells, which was associated with the production of IL8 (rho=0.636, p=0.035), HGF (rho=0.850, p=0.004), SCF (rho=0.857, p=0.014), FST (rho=0.685, p=0.029), Prolactin (rho=0.810, p=0.015), PECAM1 (rho=0.788, p=0.004).Conclusion. The technology of low-adhesive surfaces makes it possible to successfully create three-dimensional models of a tumor node from malignant tumors cells of various histogenesis. The colonization of a three-dimensional structure with fibroblasts enhances the biologically aggressive properties of tumor cells and demonstrates complex reciprocal interactions between the cellular elements of the tumor stroma and malignant cells, which brings the model closer to a real clinical situation. 


1997 ◽  
Vol 30 (2) ◽  
pp. 203-210 ◽  
Author(s):  
Shigeru Morimoto ◽  
Keiji Matsumoto ◽  
Tokuhiro Chano ◽  
Michihito Ishizawa ◽  
Sinsuke Hukuda ◽  
...  

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Kunihiro Asanuma ◽  
Tomoki Nakamura ◽  
Akinobu Hayashi ◽  
Takayuki Okamoto ◽  
Takahiro Iino ◽  
...  

2014 ◽  
Vol 25 ◽  
pp. iv506
Author(s):  
T. Matsuo ◽  
N. Hamada ◽  
H. Hachisuka ◽  
T. Hamasaki ◽  
Y. Izuta ◽  
...  

Cancers ◽  
2021 ◽  
Vol 13 (9) ◽  
pp. 2189
Author(s):  
Chiara Agnoletto ◽  
Chiara Caruso ◽  
Cecilia Garofalo

Bone and soft tissue sarcomas (STSs) represent a group of heterogeneous rare malignant tumors of mesenchymal origin, with a poor prognosis. Due to their low incidence, only a few studies have been reported addressing circulating tumor cells (CTCs) in sarcoma, despite the well-documented relevance for applications of liquid biopsy in precision medicine. In the present review, the most recent data relative to the detection and isolation of viable and intact CTCs in these tumors will be reviewed, and the heterogeneity in CTCs will be discussed. The relevance of epithelial–mesenchymal plasticity and stemness in defining the phenotypic and functional properties of these rare cells in sarcoma will be highlighted. Of note, the existence of dynamic epithelial–mesenchymal transition (EMT)-related processes in sarcoma tumors has only recently been related to their clinical aggressiveness. Also, the presence of epithelial cell adhesion molecule (EpCAM)-positive CTC in sarcoma has been weakly correlated with poor outcome and disease progression, thus proving the existence of both epithelial and mesenchymal CTC in sarcoma. The advancement in technologies for capturing and enumerating all diverse CTCs phenotype originating from these mesenchymal tumors are presented, and results provide a promising basis for clinical application of CTC detection in sarcoma.


2020 ◽  
Vol 20 (1) ◽  
pp. 132-141
Author(s):  
Javier Martín-Broto ◽  
Antonio López Pousa ◽  
Andrew S. Brohl ◽  
Brian A. Van Tine ◽  
Benjamin Powers ◽  
...  

2007 ◽  
Vol 25 (18_suppl) ◽  
pp. 5076-5076
Author(s):  
D. C. Danila ◽  
M. A. Leversha ◽  
R. Gonzalez-Espinoza ◽  
A. Anand ◽  
B. Gu ◽  
...  

5076 Background: Blood-based assays are urgently needed to provide molecular information on the specific targets expressed in tumor cells to optimize treatment selection. Antibody-capture technologies have been applied to isolate circulating tumor cells (CTC) from small volumes of peripheral blood from patients with progressive castrate metastatic prostate cancer. It has been demonstrated previously that CTC isolated from these patients represent authentic prostate cancer cells. Methods: CTC, positive for EpCAM (epithelial cellular adhesion molecule) and nuclear DAPI, and CD45 negative, were isolated from 120 patients with clinical castrate metastatic disease. All patients had rising PSA levels and were on stable treatment regimens at the time of CTC sampling. We tested the association between CTC counts and PSA levels, and the extent of disease to bone, and soft tissue metastasis by Wilcoxon rank sum. Fluorescence in situ hybridization was performed for AR and ERBB2 genes by an adapted method in CTC. Results: The average age in this patient cohort was 69 years, and median PSA at the time when CTC were drawn was 111 ng/mL (range 0.86–12147 ng/mL). The patterns of metastatic spread included disease in soft tissue only in 12 patients (10%), in bone and soft tissue in 67 (56%), and in bone only in 41 patients (34%). CTC counts ranged from 0 to 1958 cells per 7.5 mL of blood. A large number of patients (54, 45%) had 10 or more circulating tumor cells, while only 33 patients (27.5%) had 1 or less CTC per sample of blood. Significantly higher numbers of CTC were detected in patients with bone metastasis compared to those without bone metastasis (11 vs. 2.5, p<0.01). In patients with marked amplification of AR locus (five patients), tetraploidy was noted in the majority of cases (four cases). Two patients without AR amplification showed apparent tetraploidy, while no analyzed samples (nine) had amplification of ERBB2. Conclusions: The analysis of cancer-related gene alterations in CTC is feasible in a hospital-based laboratory. Further gene expression studies focused on the patients with higher numbers of CTC in correlation with clinical outcomes, as well as the investigation of CTC gene expression during specific treatments are under way. No significant financial relationships to disclose.


Oncology ◽  
1995 ◽  
Vol 52 (5) ◽  
pp. 363-370 ◽  
Author(s):  
Shigeyuki Kuratsu ◽  
Yasuhiko Tomita ◽  
Akira Myoui ◽  
Atsumasa Uchida ◽  
Keiro Ono ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document